Loading...
Header Logo
Keywords
Last Name
Institution

Natarajan Dhanasekaran

TitleProf
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentStephenson Cancer Center
Phone405/271-6590
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Madurai University, Madurai, INDIAMS1976Molecular Biology
    Indian Institute of Science, Bangalore, IndiaPhD1985Biochemistry
    National Jewish Center, Denver, COPostdoc1990Immunology

    Collapse Research 
    Collapse research activities and funding
    P20GM103639     (DHANASEKARAN, DANNY N.)Sep 5, 2012 - Jun 30, 2023
    NIH/NIGMS
    Mentoring Translational Cancer Research in Oklahoma
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Xia D, Lai DV, Wu W, Webb ZD, Yang Q, Zhao L, Yu Z, Thorpe JE, Disch BC, Ihnat MA, Jayaraman M, Dhanasekaran DN, Stratton KL, Cookson MS, Fung KM, Lin HK. Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2018 04; 178:89-98. PMID: 29155210.
      View in: PubMed
    2. Ferraresi A, Titone R, Follo C, Castiglioni A, Chiorino G, Dhanasekaran DN, Isidoro C. The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. Mol Carcinog. 2017 Dec; 56(12):2681-2691. PMID: 28856729.
      View in: PubMed
    3. Kim B, Jung JW, Jung J, Han Y, Suh DH, Kim HS, Dhanasekaran DN, Song YS. PGC1a induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells. Oncotarget. 2017 Sep 01; 8(36):60299-60311. PMID: 28947972.
      View in: PubMed
    4. Chakraborty PK, Mustafi SB, Xiong X, Dwivedi SKD, Nesin V, Saha S, Zhang M, Dhanasekaran D, Jayaraman M, Mannel R, Moore K, McMeekin S, Yang D, Zuna R, Ding K, Tsiokas L, Bhattacharya R, Mukherjee P. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634. PMID: 28530221.
      View in: PubMed
    5. Jayaraman M, Radhakrishnan R, Mathews CA, Yan M, Husain S, Moxley KM, Song YS, Dhanasekaran DN. Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer. Genes Cancer. 2017 May; 8(5-6):566-576. PMID: 28740575.
      View in: PubMed
    6. Kim S, Gwak H, Kim HS, Kim B, Dhanasekaran DN, Song YS. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget. 2016 Dec 13; 7(50):83148-83159. PMID: 27825119.
      View in: PubMed
    7. Ha JH, Yan M, Gomathinayagam R, Jayaraman M, Husain S, Liu J, Mukherjee P, Reddy EP, Song YS, Dhanasekaran DN. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer. Oncotarget. 2016 Nov 08; 7(45):72845-72859. PMID: 27655714.
      View in: PubMed
    8. Kim B, Kim HS, Kim S, Haegeman G, Tsang BK, Dhanasekaran DN, Song YS. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway. Cancer Res Treat. 2017 Apr; 49(2):338-349. PMID: 27456942.
      View in: PubMed
    9. Ha JH, Ward JD, Radhakrishnan R, Jayaraman M, Song YS, Dhanasekaran DN. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gai2, Src, and HIF1a signaling nexus. Oncotarget. 2016 Jun 21; 7(25):37664-37679. PMID: 27166196.
      View in: PubMed
    10. Nguyen CB, Kotturi H, Waris G, Mohammed A, Chandrakesan P, May R, Sureban S, Weygant N, Qu D, Rao CV, Dhanasekaran DN, Bronze MS, Houchen CW, Ali N. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Res. 2016 08 15; 76(16):4887-96. PMID: 27287718; PMCID: PMC4987271 [Available on 08/15/17].
    11. Srivastava A, Babu A, Filant J, Moxley KM, Ruskin R, Dhanasekaran D, Sood AK, McMeekin S, Ramesh R. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. J Biomed Nanotechnol. 2016 Jun; 12(6):1159-73. PMID: 27319211.
      View in: PubMed
    12. Gwak H, Kim Y, An H, Dhanasekaran DN, Song YS. Metformin induces degradation of cyclin D1 via AMPK/GSK3ß axis in ovarian cancer. Mol Carcinog. 2017 02; 56(2):349-358. PMID: 27128966.
      View in: PubMed
    13. Gwak H, Kim S, Dhanasekaran DN, Song YS. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells. Cancer Lett. 2016 Feb 28; 371(2):347-53. PMID: 26704305.
      View in: PubMed
    14. Seo JA, Kim B, Dhanasekaran DN, Tsang BK, Song YS. Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2016 Feb 01; 371(1):30-7. PMID: 26607901.
      View in: PubMed
    15. Chakraborty PK, Xiong X, Mustafi SB, Saha S, Dhanasekaran D, Mandal NA, McMeekin S, Bhattacharya R, Mukherjee P. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. 2015 Nov 10; 6(35):37367-84. PMID: 26452259; PMCID: PMC4741935.
    16. Ali N, Chandrakesan P, Nguyen CB, Husain S, Gillaspy AF, Huycke M, Berry WL, May R, Qu D, Weygant N, Sureban SM, Bronze MS, Dhanasekaran DN, Houchen CW. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget. 2015 Aug 21; 6(24):20327-44. PMID: 25948779; PMCID: PMC4653008.
    17. Yan M, Ha JH, Dhanasekaran DN. Ga13 Stimulates the Tyrosine Phosphorylation of Ric-8A. J Mol Signal. 2015 Jul 27; 10:3. PMID: 27096001; PMCID: PMC4831272.
    18. Ha JH, Gomathinayagam R, Yan M, Jayaraman M, Ramesh R, Dhanasekaran DN. Determinant role for the gep oncogenes, Ga12/13, in ovarian cancer cell proliferation and xenograft tumor growth. Genes Cancer. 2015 Jul; 6(7-8):356-364. PMID: 26413218; PMCID: PMC4575922.
    19. Song YS, Kim HS, Aoki D, Dhanasekaran DN, Tsang BK. Ovarian cancer. Biomed Res Int. 2014; 2014:764323. PMID: 25587539; PMCID: PMC4283453.
    20. Ward JD, Ha JH, Jayaraman M, Dhanasekaran DN. LPA-mediated migration of ovarian cancer cells involves translocalization of Gai2 to invadopodia and association with Src and ß-pix. Cancer Lett. 2015 Jan 28; 356(2 Pt B):382-91. PMID: 25451317; PMCID: PMC4821470.
    21. Yang YM, Lee WH, Lee CG, An J, Kim ES, Kim SH, Lee SK, Lee CH, Dhanasekaran DN, Moon A, Hwang S, Lee SJ, Park JW, Kim KM, Kim SG. Ga12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma. Oncogene. 2015 May 28; 34(22):2910-21. PMID: 25065598.
      View in: PubMed
    22. Gomathinayagam R, Muralidharan J, Ha JH, Varadarajalu L, Dhanasekaran DN. Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration. Genes Cancer. 2014 Mar; 5(3-4):84-99. PMID: 25053987; PMCID: PMC4091533.
    23. Gardner JA, Ha JH, Jayaraman M, Dhanasekaran DN. The gep proto-oncogene Ga13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells. Pancreas. 2013 Jul; 42(5):819-28. PMID: 23508014; PMCID: PMC3686977.
    24. Singhal A, Jayaraman M, Dhanasekaran DN, Kohli V. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Crit Rev Oncol Hematol. 2012 May; 82(2):116-40. PMID: 21680198.
      View in: PubMed
    25. Goldsmith ZG, Ha JH, Jayaraman M, Dhanasekaran DN. Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Ga(12). Genes Cancer. 2011 May; 2(5):563-75. PMID: 21901169; PMCID: PMC3161422.
    26. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene. 2008 Oct 20; 27(48):6245-51. PMID: 18931691; PMCID: PMC3063296.
    27. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene. 2007 May 14; 26(22):3185-202. PMID: 17496915.
      View in: PubMed
    28. Goldsmith ZG, Dhanasekaran DN. G protein regulation of MAPK networks. Oncogene. 2007 May 14; 26(22):3122-42. PMID: 17496911.
      View in: PubMed
    29. Dhanasekaran DN, Johnson GL. MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene. 2007 May 14; 26(22):3097-9. PMID: 17496908.
      View in: PubMed
    30. Jalagadugula G, Dhanasekaran DN, Kim S, Kunapuli SP, Rao AK. Early growth response transcription factor EGR-1 regulates Galphaq gene in megakaryocytic cells. J Thromb Haemost. 2006 Dec; 4(12):2678-86. PMID: 16995904.
      View in: PubMed
    31. Kumar RN, Shore SK, Dhanasekaran N. Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3. Oncogene. 2006 Feb 09; 25(6):899-906. PMID: 16247467.
      View in: PubMed
    32. Radhika V, Hee Ha J, Jayaraman M, Tsim ST, Dhanasekaran N. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12. Oncogene. 2005 Jun 30; 24(28):4597-603. PMID: 15856019.
      View in: PubMed
    33. Radhika V, Milkevitch M, Audigé V, Proikas-Cezanne T, Dhanasekaran N. Engineered Saccharomyces cerevisiae strain BioS-1, for the detection of water-borne toxic metal contaminants. Biotechnol Bioeng. 2005 Apr 05; 90(1):29-35. PMID: 15712302.
      View in: PubMed
    34. Kumar RN, Radhakrishnan R, Ha JH, Dhanasekaran N. Proteome analysis of NIH3T3 cells transformed by activated Galpha12: regulation of leukemia-associated protein SET. J Proteome Res. 2004 Nov-Dec; 3(6):1177-83. PMID: 15595726.
      View in: PubMed
    35. Vedhachalam C, Liu L, Nickel M, Dhanasekaran P, Anantharamaiah GM, Lund-Katz S, Rothblat GH, Phillips MC. Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids. J Biol Chem. 2004 Nov 26; 279(48):49931-9. PMID: 15383537.
      View in: PubMed
    36. Radhika V, Onesime D, Ha JH, Dhanasekaran N. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem. 2004 Nov 19; 279(47):49406-13. PMID: 15339924.
      View in: PubMed
    37. Goldsmith ZG, Dhanasekaran N. The microrevolution: applications and impacts of microarray technology on molecular biology and medicine (review). Int J Mol Med. 2004 Apr; 13(4):483-95. PMID: 15010847.
      View in: PubMed
    38. Dermott JM, Ha JH, Lee CH, Dhanasekaran N. Differential regulation of Jun N-terminal kinase and p38MAP kinase by Galpha12. Oncogene. 2004 Jan 08; 23(1):226-32. PMID: 14712227.
      View in: PubMed
    39. Kumar RN, Radhika V, Audigé V, Rane SG, Dhanasekaran N. Proliferation-specific genes activated by Galpha(12): a role for PDGFRalpha and JAK3 in Galpha(12)-mediated cell proliferation. Cell Biochem Biophys. 2004; 41(1):63-73. PMID: 18038259.
      View in: PubMed
    40. Peter AT, Dhanasekaran N. Apoptosis of granulosa cells: a review on the role of MAPK-signalling modules. Reprod Domest Anim. 2003 Jun; 38(3):209-13. PMID: 12753555.
      View in: PubMed
    41. Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A. 2002 Oct 29; 99(22):14189-94. PMID: 12391307; PMCID: PMC137859.
    42. Gabbeta J, Vaidyula VR, Dhanasekaran DN, Rao AK. Human platelet Galphaq deficiency is associated with decreased Galphaq gene expression in platelets but not neutrophils. Thromb Haemost. 2002 Jan; 87(1):129-33. PMID: 11848441.
      View in: PubMed
    43. Dermott JM, Dhanasekaran N. Determining cellular role of G alpha 12. Methods Enzymol. 2002; 344:298-309. PMID: 11771390.
      View in: PubMed
    44. Radhika V, Dhanasekaran N. Transforming G proteins. Oncogene. 2001 Mar 26; 20(13):1607-14. PMID: 11313908.
      View in: PubMed
    45. Dermott JM, Wadsworth SJ, van Rossum GD, Dhanasekaran N. Activated mutant of Galpha(12) enhances the hyperosmotic stress response of NIH3T3 cells. J Cell Biochem. 2001; 81(1):1-8. PMID: 11180393.
      View in: PubMed
    46. Ha JH, Dhanasekaran N, Koh HC, Lee CH. Single amino acid of g(alpha16) (Ala(228)) is responsible for the ability of chemoattractant C5a receptor to induce G(alpha16)-mediated inositol phosphate release. Biochem Biophys Res Commun. 2000 Nov 19; 278(2):426-31. PMID: 11097853.
      View in: PubMed
    47. Gebauer G, Mirakhur B, Nguyen Q, Shore SK, Simpkins H, Dhanasekaran N. Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells. Int J Oncol. 2000 Feb; 16(2):321-5. PMID: 10639576.
      View in: PubMed
    48. Gebauer G, Peter AT, Onesime D, Dhanasekaran N. Apoptosis of ovarian granulosa cells: correlation with the reduced activity of ERK-signaling module. J Cell Biochem. 1999 Dec 15; 75(4):547-54. PMID: 10572238.
      View in: PubMed
    49. Dermott JM, Reddy MR, Onesime D, Reddy EP, Dhanasekaran N. Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene. 1999 Dec 02; 18(51):7185-9. PMID: 10602471.
      View in: PubMed
    50. Vara Prasad MV, Dhanasekaran N. GTPase deficient mutant of G(alpha13) regulates the expression of Egr-1 through the small GTPase Rho. Oncogene. 1999 Feb 25; 18(8):1639-42. PMID: 10102635.
      View in: PubMed
    51. Dhanasekaran N, Wu YK, Reece EA. Signaling pathways and diabetic embryopathy. Semin Reprod Endocrinol. 1999; 17(2):167-74. PMID: 10528367.
      View in: PubMed
    52. Dhanasekaran N, Premkumar Reddy E. Signaling by dual specificity kinases. Oncogene. 1998 Sep 17; 17(11 Reviews):1447-55. PMID: 9779990.
      View in: PubMed
    53. Dhanasekaran N. Cell signaling: an overview. Oncogene. 1998 Sep 17; 17(11 Reviews):1329-30. PMID: 9779980.
      View in: PubMed
    54. Dhanasekaran N, Tsim ST, Dermott JM, Onesime D. Regulation of cell proliferation by G proteins. Oncogene. 1998 Sep 17; 17(11 Reviews):1383-94. PMID: 9779986.
      View in: PubMed
    55. Gabbeta J, Dhanasekaran N, Rao AK. G alpha q cDNA sequence from human platelets. Thromb Res. 1998 Jul 01; 91(1):29-32. PMID: 9700850.
      View in: PubMed
    56. Dhanasekaran N, Prasad MV. G protein subunits and cell proliferation. Biol Signals Recept. 1998 Mar-Apr; 7(2):109-17. PMID: 9629462.
      View in: PubMed
    57. Walsh AB, Dhanasekaran M, Bar-Sagi D, Kumar CC. SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway. Oncogene. 1997 Nov 20; 15(21):2553-60. PMID: 9399643.
      View in: PubMed
    58. Wadsworth SJ, Gebauer G, van Rossum GD, Dhanasekaran N. Ras-dependent signaling by the GTPase-deficient mutant of Galpha12. J Biol Chem. 1997 Nov 14; 272(46):28829-32. PMID: 9360946.
      View in: PubMed
    59. Kelsen SG, Anakwe O, Aksoy MO, Reddy PJ, Dhanasekaran N. IL-1 beta alters beta-adrenergic receptor adenylyl cyclase system function in human airway epithelial cells. Am J Physiol. 1997 Sep; 273(3 Pt 1):L694-700. PMID: 9316506.
      View in: PubMed
    60. Gabbeta J, Yang X, Kowalska MA, Sun L, Dhanasekaran N, Rao AK. Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses. Proc Natl Acad Sci U S A. 1997 Aug 05; 94(16):8750-5. PMID: 9238049; PMCID: PMC23110.
    61. Wang P, Dhanasekaran N, Luthin GR. ERK activation and cellular proliferation in response to muscarinic acetylcholine receptor agonists. Ann N Y Acad Sci. 1997 May 30; 812:182-3. PMID: 9186737.
      View in: PubMed
    62. Luthin GR, Wang P, Zhou H, Dhanasekaran D, Ruggieri MR. Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sci. 1997; 60(13-14):963-8. PMID: 9121362.
      View in: PubMed
    63. Dhanasekaran N, Dermott JM. Signaling by the G12 class of G proteins. Cell Signal. 1996 Jun; 8(4):235-45. PMID: 8842523.
      View in: PubMed
    64. Vaillancourt RR, Dhanasekaran N, Ruoho AE. The photoactivatable NAD+ analogue [32P]2-azido-NAD+ defines intra- and inter-molecular interactions of the C-terminal domain of the G-protein G alpha t. Biochem J. 1995 Nov 01; 311 ( Pt 3):987-93. PMID: 7487961; PMCID: PMC1136099.
    65. Buhl AM, Johnson NL, Dhanasekaran N, Johnson GL. G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem. 1995 Oct 20; 270(42):24631-4. PMID: 7559569.
      View in: PubMed
    66. Prasad MV, Dermott JM, Heasley LE, Johnson GL, Dhanasekaran N. Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of G alpha 12 and G alpha 13. J Biol Chem. 1995 Aug 04; 270(31):18655-9. PMID: 7629196.
      View in: PubMed
    67. Rambhatla L, Patel B, Dhanasekaran N, Latham KE. Analysis of G protein alpha subunit mRNA abundance in preimplantation mouse embryos using a rapid, quantitative RT-PCR approach. Mol Reprod Dev. 1995 Jul; 41(3):314-24. PMID: 8588930.
      View in: PubMed
    68. Dhanasekaran N, Heasley LE, Johnson GL. G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev. 1995 Jun; 16(3):259-70. PMID: 7671848.
      View in: PubMed
    69. Vara Prasad MV, Shore SK, Dhanasekaran N. Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene. 1994 Aug; 9(8):2425-9. PMID: 8036026.
      View in: PubMed
    70. Dhanasekaran N, Prasad MV, Wadsworth SJ, Dermott JM, van Rossum G. Protein kinase C-dependent and -independent activation of Na+/H+ exchanger by G alpha 12 class of G proteins. J Biol Chem. 1994 Apr 22; 269(16):11802-6. PMID: 8163478.
      View in: PubMed
    71. Vaillancourt RR, Dhanasekaran N, Ruoho AE. Synthesis and use of radioactive photoactivatable NAD+ derivatives as probes for G-protein structure. Methods Enzymol. 1994; 237:70-99. PMID: 7935026.
      View in: PubMed
    72. Gupta SK, Dhanasekaran N, Heasley LE, Johnson GL. Activating mutations in the NH2- and COOH-terminal moieties of the Gs alpha subunit have dominant phenotypes and distinguishable kinetics of adenylyl cyclase stimulation. J Cell Biochem. 1991 Dec; 47(4):359-68. PMID: 1665495.
      View in: PubMed
    73. Dhanasekaran N, Osawa S, Johnson GL. The NH2-terminal alpha subunit attenuator domain confers regulation of G protein activation by beta gamma complexes. J Cell Biochem. 1991 Dec; 47(4):352-8. PMID: 1795017.
      View in: PubMed
    74. Johnson GL, Dhanasekaran N, Gupta SK, Lowndes JM, Vaillancourt RR, Ruoho AE. Genetic and structural analysis of G protein alpha subunit regulatory domains. J Cell Biochem. 1991 Oct; 47(2):136-46. PMID: 1661737.
      View in: PubMed
    75. Osawa S, Dhanasekaran N, Woon CW, Johnson GL. G alpha i-G alpha s chimeras define the function of alpha chain domains in control of G protein activation and beta gamma subunit complex interactions. Cell. 1990 Nov 16; 63(4):697-706. PMID: 2121366.
      View in: PubMed
    76. Osawa S, Heasley LE, Dhanasekaran N, Gupta SK, Woon CW, Berlot C, Johnson GL. Mutation of the Gs protein alpha subunit NH2 terminus relieves an attenuator function, resulting in constitutive adenylyl cyclase stimulation. Mol Cell Biol. 1990 Jun; 10(6):2931-40. PMID: 1692962; PMCID: PMC360656.
    77. Vaillancourt RR, Dhanasekaran N, Johnson GL, Ruoho AE. 2-Azido-[32P]NAD+, a photoactivatable probe for G-protein structure: evidence for holotransducin oligomers in which the ADP-ribosylated carboxyl terminus of alpha interacts with both alpha and gamma subunits. Proc Natl Acad Sci U S A. 1990 May; 87(10):3645-9. PMID: 2111013; PMCID: PMC53959.
    78. Heasley LE, Dhanasekaran N, Gupta SK, Osawa S, Johnson GL. Chimeras of the Gs alpha subunit that had the NH2- or COOH-terminal sequence substituted for the corresponding region of the Gi alpha subunit constitutively activate adenylyl cyclase. Soc Gen Physiol Ser. 1990; 45:117-24. PMID: 2165634.
      View in: PubMed
    79. Dhanasekaran N, Moudgal NR. Biochemical and histological validation of a model to study follicular atresia in rats. Endocrinol Exp. 1989 Sep; 23(3):155-66. PMID: 2806185.
      View in: PubMed
    80. Johnson GL, Dhanasekaran N. The G-protein family and their interaction with receptors. Endocr Rev. 1989 Aug; 10(3):317-31. PMID: 2550214.
      View in: PubMed
    81. Dhanasekaran N, Moudgal NR. Studies on follicular atresia: role of gonadotropins and gonadal steroids in regulating cathepsin-D activity of preovulatory follicles in the rat. Mol Cell Endocrinol. 1989 May; 63(1-2):133-42. PMID: 2502456.
      View in: PubMed
    82. Dhanasekaran N, Wessling-Resnick M, Kelleher DJ, Johnson GL, Ruoho AE. Mapping of the carboxyl terminus within the tertiary structure of transducin's alpha subunit using the heterobifunctional cross-linking reagent, 125I-N-(3-iodo-4-azidophenylpropionamido-S-(2-thiopyridyl) cysteine. J Biol Chem. 1988 Dec 05; 263(34):17942-50. PMID: 3192520.
      View in: PubMed
    83. Dhanasekaran N, Moudgal NR. Gonadotropin regulation of rat ovarian lysosomes: existence of a hormone specific dual control mechanism. Biosci Rep. 1988 Jun; 8(3):279-85. PMID: 3145041.
      View in: PubMed
    84. Dhanasekaran N, Moudgal NR. Studies on follicular atresia: role of tropic hormone and steroids in regulating cathepsin-D activity of preantral follicles of the immature rat. Mol Cell Endocrinol. 1986 Jan; 44(1):77-84. PMID: 3081387.
      View in: PubMed
    85. Dhanasekaran N, Sheela Rani CS, Moudgal NR. Studies on follicular atresia: lysosomal enzyme activity and gonadotropin receptors of granulosa cells following administration or withdrawal of gonadotropins in the rat. Mol Cell Endocrinol. 1983 Nov; 33(1):97-112. PMID: 6315511.
      View in: PubMed
    Dhanasekaran's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description